CelgenTek Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

CelgenTek General Information

Description

Developer of orthobiologics implants intended to treat bone diseases. The company develops, manufactures and distributes medical and biological implants for use in the treatment of compromised bones, enabling healthcare providers to offer better patient outcomes in treatments such as bone augmentation in osteoporosis, and infection and avascular necrosis.

Contact Information

Website
www.celgentek.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Western Business Park
  • Unit 4D
  • Shannon V14 RW92
  • Ireland
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Zimmer Biomet Holdings
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Western Business Park
  • Unit 4D
  • Shannon V14 RW92
  • Ireland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CelgenTek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Jul-2019 000 Completed Generating Revenue
2. Seed Round 15-Dec-2015 000 000 Completed Startup
1. Grant 03-Dec-2015 $53.7K Completed Startup
To view CelgenTek’s complete valuation and funding history, request access »

CelgenTek Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

CelgenTek Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11160595-B2 System, device and method for delivery of biomaterials for fracture fixation Active 15-Apr-2015 00000000000 00
US-20180132918-A1 System, device and method for delivery of biomaterials for fracture fixation Active 15-Apr-2015 00000000000 0
AU-2016249965-B2 System, device and method for delivery of biomaterials for fracture fixation Active 15-Apr-2015 00000000000 0
EP-3282986-A2 System, device and method for delivery of biomaterials for fracture fixation Active 15-Apr-2015 00000000000
EP-3282986-B1 System for delivery of biomaterials for fracture fixation Active 15-Apr-2015 A61B17/7098 0
To view CelgenTek’s complete patent history, request access »

CelgenTek Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CelgenTek Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bank of Ireland Corporation 000 0000 000000 0
To view CelgenTek’s complete investors history, request access »

Ready to get started?

Request a free trial

CelgenTek FAQs

  • When was CelgenTek founded?

    CelgenTek was founded in 2014.

  • Who is the founder of CelgenTek?

    Zarko Bajic is the founder of CelgenTek.

  • Where is CelgenTek headquartered?

    CelgenTek is headquartered in Shannon, Ireland.

  • What is the size of CelgenTek?

    CelgenTek has 21 total employees.

  • What industry is CelgenTek in?

    CelgenTek’s primary industry is Therapeutic Devices.

  • Is CelgenTek a private or public company?

    CelgenTek is a Private company.

  • What is CelgenTek’s current revenue?

    The current revenue for CelgenTek is 00000.

  • How much funding has CelgenTek raised over time?

    CelgenTek has raised $2M.

  • Who are CelgenTek’s investors?

    Bank of Ireland has invested in CelgenTek.

  • When was CelgenTek acquired?

    CelgenTek was acquired on 09-Jul-2019.

  • Who acquired CelgenTek?

    CelgenTek was acquired by Zimmer Biomet Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »